" class="no-js "lang="en-US"> Seamless Therapeutics - Medtech Alert
Friday, March 29, 2024
Seamless Therapeutics | MTA

Seamless Therapeutics

About Seamless Therapeutics

Seamless Therapeutics
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing.

Related Story

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform

March 16 2023

Seamless Therapeutics today announced a $12.5 million (€11.8M) seed financing round which will accelerate further […]